Advanced Prosthetic Foot Technology Manufacturer with Proprietary IP

This is a premium U.S.-based manufacturer specializing in advanced prosthetic foot technology, offering lower-limb solutions for amputees. The company holds 25 CMS-approved PDAC billing codes, providing high reimbursement potential and premium margins within the prosthetic foot segment. Strategically positioned in the rapidly expanding $1.6 billion diabetic foot loss market, the business leverages aerospace-derived composite materials for lightweight, durable, and flexible prosthetic systems. Key differentiators include proprietary manufacturing, efficient unit economics, and scalability. Customer acquisition is driven by B2B relationships and direct marketing, with a new multi-channel campaign underway. The business offers a fully operational, regulatory-compliant platform with national scalability and minimal capital investment, presenting a high barrier to entry for competitors. The founder, an innovator, is seeking an operator to scale the business after market validation.